B Hoogwerf

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi Drug selection and the management of corticosteroid-related diabetes mellitus
    B Hoogwerf
    Department of Endocrinology, Cleveland Clinic Foundation, Ohio, USA
    Rheum Dis Clin North Am 25:489-505. 1999
  2. ncbi Advances in the treatment of diabetes mellitus in the elderly. Development of insulin analogues
    B J Hoogwerf
    Department of Endocrinology, Cleveland Clinic Foundation, Ohio, USA
    Drugs Aging 9:438-48. 1996
  3. ncbi Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial
    B J Hoogwerf
    Cleveland Clinic Foundation, OH 44195, USA
    Diabetes 48:1289-94. 1999

Detail Information

Publications3

  1. ncbi Drug selection and the management of corticosteroid-related diabetes mellitus
    B Hoogwerf
    Department of Endocrinology, Cleveland Clinic Foundation, Ohio, USA
    Rheum Dis Clin North Am 25:489-505. 1999
    ..The effects of glucocorticoids on hyperglycemia usually remit within 48 hours of discontinuation of oral administration...
  2. ncbi Advances in the treatment of diabetes mellitus in the elderly. Development of insulin analogues
    B J Hoogwerf
    Department of Endocrinology, Cleveland Clinic Foundation, Ohio, USA
    Drugs Aging 9:438-48. 1996
    ....
  3. ncbi Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial
    B J Hoogwerf
    Cleveland Clinic Foundation, OH 44195, USA
    Diabetes 48:1289-94. 1999
    ..The small number of diabetic patients provided limited power to detect significant differences between diabetic and nondiabetic patients or between diabetic patients in the aggressive versus moderate cholesterol treatment strategies...